312 Female sex independently predicts adjuvant immunotherapeutic benefit from CTLA4 immune checkpoint inhibition

MLA

Howard Striecher, et al. “312 Female Sex Independently Predicts Adjuvant Immunotherapeutic Benefit from CTLA4 Immune Checkpoint Inhibition.” Regular and Young Investigator Award Abstracts, Nov. 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....358ab2ec0b89e8eb146d7fa320650442&authtype=sso&custid=ns315887.

APA

Howard Striecher, Gary I. Cohen, Teresa M. Petrella, Kari Kendra, H. Kluger, Sandra J. Lee, Lawrence E. Flaherty, Ni Kang, F. Stephen Hodi, Jeffrey A. Sosman, Omid Hamid, Carrie B. Lee, Laura F. Hutchins, Donald P. Lawrence, Henry B. Koon, Vernon K. Sondak, Mark R. Albertini, John M. Kirkwood, David R. Minor, … Ahmad A. Tarhini. (2020). 312 Female sex independently predicts adjuvant immunotherapeutic benefit from CTLA4 immune checkpoint inhibition. Regular and Young Investigator Award Abstracts.

Chicago

Howard Striecher, Gary I. Cohen, Teresa M. Petrella, Kari Kendra, H. Kluger, Sandra J. Lee, Lawrence E. Flaherty, et al. 2020. “312 Female Sex Independently Predicts Adjuvant Immunotherapeutic Benefit from CTLA4 Immune Checkpoint Inhibition.” Regular and Young Investigator Award Abstracts, November. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....358ab2ec0b89e8eb146d7fa320650442&authtype=sso&custid=ns315887.